{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T17:39:30Z","timestamp":1766165970127,"version":"3.48.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"DOI":"10.7759\/cureus.99640","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T17:37:07Z","timestamp":1766165827000},"source":"Crossref","is-referenced-by-count":0,"title":["Inflammation Beyond the Prostate: The Role of Systemic Inflammatory Disorders in Prostate Carcinogenesis"],"prefix":"10.7759","author":[{"given":"Gurjit K","family":"Bhatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishtiaq","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anushka","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inderpal S","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasvinder  S","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawaljit S","family":"Kaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla P","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019, 10:63-89. 10.14740\/wjon1191","journal-title":"World J Oncol"},{"key":"ref2","article-title":"The etiology of prostate cancer","author":"Ng KL","year":"2021","unstructured":"Ng KL. The etiology of prostate cancer. Prostate Cancer. Bott SR, Ng KL (ed): Frimley Park Hospital, Cambridge, UK; 2021."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2011.04033.x","article-title":"Prostate cancer and inflammation: the evidence","volume":"60","author":"Sfanos KS","year":"2012","unstructured":"Sfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology. 2012, 60:199-215. 10.1111\/j.1365-2559.2011.04033.x","journal-title":"Histopathology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101755","article-title":"Chronic inflammation and the hallmarks of aging","volume":"74","author":"Baechle JJ","year":"2023","unstructured":"Baechle JJ, Chen N, Makhijani P, Winer S, Furman D, Winer DA. Chronic inflammation and the hallmarks of aging. Mol Metab. 2023, 74:10.1016\/j.molmet.2023.101755","journal-title":"Mol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2025.0149","article-title":"The immune landscape of systemic inflammation in prostate cancer","volume":"22","author":"Zhang L","year":"2025","unstructured":"Zhang L, Fu J, Liu X, Feng S, Leng Y. The immune landscape of systemic inflammation in prostate cancer. Cancer Biol Med. 2025, 22:881-902. 10.20892\/j.issn.2095-3941.2025.0149","journal-title":"Cancer Biol Med"},{"key":"ref6","article-title":"Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer","volume":"32","author":"Franks AL","year":"2012","unstructured":"Franks AL, Slansky JE. Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res. 2012, 32:1119-36.","journal-title":"Anticancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102882","article-title":"Autoimmunity and cancer","volume":"20","author":"Masetti R","year":"2021","unstructured":"Masetti R, Tiri A, Tignanelli A, Turrini E, Argentiero A, Pession A, Esposito S. Autoimmunity and cancer. Autoimmun Rev. 2021, 20:10.1016\/j.autrev.2021.102882","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8020201","article-title":"Obesity, inflammation, and prostate cancer","volume":"8","author":"Fujita K","year":"2019","unstructured":"Fujita K, Hayashi T, Matsushita M, Uemura M, Nonomura N. Obesity, inflammation, and prostate cancer. J Clin Med. 2019, 8:10.3390\/jcm8020201","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz058","article-title":"Inflammation: a common contributor to cancer, aging, and cardiovascular diseases - expanding the concept of cardio-oncology","volume":"115","author":"Libby P","year":"2019","unstructured":"Libby P, Kobold S. Inflammation: a common contributor to cancer, aging, and cardiovascular diseases - expanding the concept of cardio-oncology. Cardiovasc Res. 2019, 115:824-9. 10.1093\/cvr\/cvz058","journal-title":"Cardiovasc Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0149","article-title":"Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe","volume":"15","author":"Aggarwal BB","year":"2009","unstructured":"Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res. 2009, 15:425-30. 10.1158\/1078-0432.CCR-08-0149","journal-title":"Clin Cancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25815","article-title":"Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates","volume":"128","author":"Lonkar P","year":"2011","unstructured":"Lonkar P, Dedon PC. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer. 2011, 128:1999-2009. 10.1002\/ijc.25815","journal-title":"Int J Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/RRU.S23386","article-title":"The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer","volume":"5","author":"Elkahwaji JE","year":"2012","unstructured":"Elkahwaji JE. The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer. Res Rep Urol. 2012, 5:1-10. 10.2147\/RRU.S23386","journal-title":"Res Rep Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.10729","article-title":"NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?","volume":"91","author":"Suh J","year":"2004","unstructured":"Suh J, Rabson AB. NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?. J Cell Biochem. 2004, 91:100-17. 10.1002\/jcb.10729","journal-title":"J Cell Biochem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1133013","article-title":"Mechanism of inflammasomes in cancer and targeted therapies","volume":"13","author":"Gu Q","year":"2023","unstructured":"Gu Q, Zou J, Zhou Y, Deng Q. Mechanism of inflammasomes in cancer and targeted therapies. Front Oncol. 2023, 13:10.3389\/fonc.2023.1133013","journal-title":"Front Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10100352","article-title":"Targeting crosstalk between Nrf-2, NF-\u03baB and androgen receptor signaling in prostate cancer","volume":"10","author":"Khurana N","year":"2018","unstructured":"Khurana N, Sikka SC. Targeting crosstalk between Nrf-2, NF-\u03baB and androgen receptor signaling in prostate cancer. Cancers (Basel). 2018, 10:10.3390\/cancers10100352","journal-title":"Cancers (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-01829-4","article-title":"The heat of the battle: inflammation's role in prostate cancer development and inflammation-targeted therapies","volume":"16","author":"Sharma U","year":"2025","unstructured":"Sharma U, Sahu A, Shekhar H, et al.. The heat of the battle: inflammation's role in prostate cancer development and inflammation-targeted therapies. Discov Oncol. 2025, 16:10.1007\/s12672-025-01829-4","journal-title":"Discov Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.721989","article-title":"The role of C-reactive protein in kidney, bladder, and prostate cancers","volume":"12","author":"O'Brian D","year":"2021","unstructured":"O'Brian D, Prunty M, Hill A, Shoag J. The role of C-reactive protein in kidney, bladder, and prostate cancers. Front Immunol. 2021, 12:10.3389\/fimmu.2021.721989","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.123686","article-title":"Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis","volume":"16","author":"Liu ZQ","year":"2014","unstructured":"Liu ZQ, Chu L, Fang JM, Zhang X, Zhao HX, Chen YJ, Xu Q. Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis. Asian J Androl. 2014, 16:467-71. 10.4103\/1008-682X.123686","journal-title":"Asian J Androl"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.545603","article-title":"Genetically predicted circulating level of C-reactive protein is not associated with prostate cancer risk","volume":"10","author":"He C","year":"2020","unstructured":"He C, Qian Y, Liu B, et al.. Genetically predicted circulating level of C-reactive protein is not associated with prostate cancer risk. Front Oncol. 2020, 10:10.3389\/fonc.2020.545603","journal-title":"Front Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03924-y","article-title":"Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis","volume":"21","author":"Meng L","year":"2023","unstructured":"Meng L, Yang Y, Hu X, Zhang R, Li X. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis. J Transl Med. 2023, 21:10.1186\/s12967-023-03924-y","journal-title":"J Transl Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012504","article-title":"Prognostic role of platelet to lymphocyte ratio in prostate cancer: a meta-analysis","volume":"97","author":"Wang J","year":"2018","unstructured":"Wang J, Zhou X, He Y, Chen X, Liu N, Ding Z, Li J. Prognostic role of platelet to lymphocyte ratio in prostate cancer: a meta-analysis. Medicine (Baltimore). 2018, 97:10.1097\/MD.0000000000012504","journal-title":"Medicine (Baltimore)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S385308","article-title":"The systemic inflammation score is associated with the survival of patients with prostate cancer","volume":"16","author":"Xie J","year":"2023","unstructured":"Xie J, Xiao X, Dong Z, Wang Q. The systemic inflammation score is associated with the survival of patients with prostate cancer. J Inflamm Res. 2023, 16:963-75. 10.2147\/JIR.S385308","journal-title":"J Inflamm Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003540","article-title":"Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: a nationwide population-based dynamic cohort study in Taiwan","volume":"95","author":"Yu KH","year":"2016","unstructured":"Yu KH, Kuo CF, Huang LH, Huang WK, See LC. Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: a nationwide population-based dynamic cohort study in Taiwan. Medicine (Baltimore). 2016, 95:10.1097\/MD.0000000000003540","journal-title":"Medicine (Baltimore)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/ar2417","article-title":"The relationship between cancer and rheumatoid arthritis: still a large research agenda","volume":"10","author":"Love T","year":"2008","unstructured":"Love T, Solomon DH. The relationship between cancer and rheumatoid arthritis: still a large research agenda. Arthritis Res Ther. 2008, 10:10.1186\/ar2417","journal-title":"Arthritis Res Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-017-0064-4","article-title":"Malignancy incidence, management, and prevention in patients with rheumatoid arthritis","volume":"4","author":"Wilton KM","year":"2017","unstructured":"Wilton KM, Matteson EL. Malignancy incidence, management, and prevention in patients with rheumatoid arthritis. Rheumatol Ther. 2017, 4:333-47. 10.1007\/s40744-017-0064-4","journal-title":"Rheumatol Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1482-y","article-title":"The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs","volume":"19","author":"Cho SK","year":"2017","unstructured":"Cho SK, Lee J, Han M, Bae SC, Sung YK. The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs. Arthritis Res Ther. 2017, 19:10.1186\/s13075-017-1482-y","journal-title":"Arthritis Res Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107719","article-title":"Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort","volume":"97","author":"England BR","year":"2021","unstructured":"England BR, Campany M, Sayles H, et al.. Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort. Int Immunopharmacol. 2021, 97:10.1016\/j.intimp.2021.107719","journal-title":"Int Immunopharmacol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/cells7120223","article-title":"Defective T-cell apoptosis and T-regulatory cell dysfunction in rheumatoid arthritis","volume":"7","author":"Malemud CJ","year":"2018","unstructured":"Malemud CJ. Defective T-cell apoptosis and T-regulatory cell dysfunction in rheumatoid arthritis. Cells. 2018, 7:10.3390\/cells7120223","journal-title":"Cells"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang Y","year":"2015","unstructured":"Jiang Y, Li Y, Zhu B. T-cell exhaustion in the tumor microenvironment. Cell Death Dis. 2015, 6:10.1038\/cddis.2015.162","journal-title":"Cell Death Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601814","article-title":"Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer","volume":"90","author":"Michalaki V","year":"2004","unstructured":"Michalaki V, Syrigos K, Charles P, Waxman J. Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer. 2004, 90:2312-6. 10.1038\/sj.bjc.6601814","journal-title":"Br J Cancer"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155238","article-title":"Interleukin-6 in rheumatoid arthritis","volume":"21","author":"Pandolfi F","year":"2020","unstructured":"Pandolfi F, Franza L, Carusi V, Altamura S, Andriollo G, Nucera E. Interleukin-6 in rheumatoid arthritis. Int J Mol Sci. 2020, 21:10.3390\/ijms21155238","journal-title":"Int J Mol Sci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23784","article-title":"Consequences of interleukin 1\u03b2-triggered chronic inflammation in the mouse prostate gland: altered architecture associated with prolonged CD4(+) infiltration mimics human proliferative inflammatory atrophy","volume":"79","author":"Ashok A","year":"2019","unstructured":"Ashok A, Keener R, Rubenstein M, et al.. Consequences of interleukin 1\u03b2-triggered chronic inflammation in the mouse prostate gland: altered architecture associated with prolonged CD4(+) infiltration mimics human proliferative inflammatory atrophy. Prostate. 2019, 79:732-45. 10.1002\/pros.23784","journal-title":"Prostate"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46609","article-title":"Pan-Immune-Inflammation Index as a biomarker for rheumatoid arthritis progression and diagnosis","volume":"15","author":"Tutan D","year":"2023","unstructured":"Tutan D, Do\u011fan AG. Pan-Immune-Inflammation Index as a biomarker for rheumatoid arthritis progression and diagnosis. Cureus. 2023, 15:10.7759\/cureus.46609","journal-title":"Cureus"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06122-1","article-title":"Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study","volume":"41","author":"Xu Y","year":"2022","unstructured":"Xu Y, He H, Zang Y, et al.. Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multi-center retrospective study. Clin Rheumatol. 2022, 41:1989-2000. 10.1007\/s10067-022-06122-1","journal-title":"Clin Rheumatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1446160","article-title":"The association between the aggregate index of systemic inflammation and risk of rheumatoid arthritis: retrospective analysis of NHANES 1999-2018","volume":"11","author":"Yin X","year":"2024","unstructured":"Yin X, Zou J, Yang J. The association between the aggregate index of systemic inflammation and risk of rheumatoid arthritis: retrospective analysis of NHANES 1999-2018. Front Med (Lausanne). 2024, 11:10.3389\/fmed.2024.1446160","journal-title":"Front Med (Lausanne)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: weighing the evidence","volume":"63","author":"Allott EH","year":"2013","unstructured":"Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013, 63:800-9. 10.1016\/j.eururo.2012.11.013","journal-title":"Eur Urol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1042\/CS20200895","article-title":"The complex role of adipokines in obesity, inflammation, and autoimmunity","volume":"135","author":"Taylor EB","year":"2021","unstructured":"Taylor EB. The complex role of adipokines in obesity, inflammation, and autoimmunity. Clin Sci (Lond). 2021, 135:731-52. 10.1042\/CS20200895","journal-title":"Clin Sci (Lond)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0911","article-title":"Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation","volume":"56","author":"Hosogai N","year":"2007","unstructured":"Hosogai N, Fukuhara A, Oshima K, et al.. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes. 2007, 56:901-11. 10.2337\/db06-0911","journal-title":"Diabetes"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI19451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu H","year":"2003","unstructured":"Xu H, Barnes GT, Yang Q, et al.. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003, 112:1821-30. 10.1172\/JCI19451","journal-title":"J Clin Invest"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00332","article-title":"Role of adipokines signaling in the modulation of T cells function","volume":"4","author":"Procaccini C","year":"2013","unstructured":"Procaccini C, De Rosa V, Galgani M, Carbone F, La Rocca C, Formisano L, Matarese G. Role of adipokines signaling in the modulation of T cells function. Front Immunol. 2013, 4:10.3389\/fimmu.2013.00332","journal-title":"Front Immunol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjae039","article-title":"Hypoxia signaling in the adipose tissue","volume":"16","author":"Huynh PM","year":"2025","unstructured":"Huynh PM, Wang F, An YA. Hypoxia signaling in the adipose tissue. J Mol Cell Biol. 2025, 16:10.1093\/jmcb\/mjae039","journal-title":"J Mol Cell Biol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.686709","article-title":"Hypoxia potentiates palmitate-induced pro-inflammatory activation of primary human macrophages","volume":"291","author":"Snodgrass RG","year":"2016","unstructured":"Snodgrass RG, Bo\u00df M, Zezina E, et al.. Hypoxia potentiates palmitate-induced pro-inflammatory activation of primary human macrophages. J Biol Chem. 2016, 291:413-24. 10.1074\/jbc.M115.686709","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0930","article-title":"Molecular pathways: adiponectin and leptin signaling in cancer","volume":"19","author":"Vansaun MN","year":"2013","unstructured":"Vansaun MN. Molecular pathways: adiponectin and leptin signaling in cancer. Clin Cancer Res. 2013, 19:1926-32. 10.1158\/1078-0432.CCR-12-0930","journal-title":"Clin Cancer Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2004.07.031","article-title":"Leptin induces cell migration and the expression of growth factors in human prostate cancer cells","volume":"188","author":"Frankenberry KA","year":"2004","unstructured":"Frankenberry KA, Somasundar P, McFadden DW, Vona-Davis LC. Leptin induces cell migration and the expression of growth factors in human prostate cancer cells. Am J Surg. 2004, 188:560-5. 10.1016\/j.amjsurg.2004.07.031","journal-title":"Am J Surg"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22455","article-title":"Leptin increases motility and integrin up-regulation in human prostate cancer cells","volume":"226","author":"Huang CY","year":"2011","unstructured":"Huang CY, Yu HS, Lai TY, et al.. Leptin increases motility and integrin up-regulation in human prostate cancer cells. J Cell Physiol. 2011, 226:1274-82. 10.1002\/jcp.22455","journal-title":"J Cell Physiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence","volume":"33","author":"Dalamaga M","year":"2012","unstructured":"Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012, 33:547-94. 10.1210\/er.2011-1015","journal-title":"Endocr Rev"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79345-4","article-title":"Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis","volume":"11","author":"Burton AJ","year":"2021","unstructured":"Burton AJ, Gilbert R, Tilling K, Langdon R, Donovan JL, Holly JM, Martin RM. Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis. Sci Rep. 2021, 11:10.1038\/s41598-020-79345-4","journal-title":"Sci Rep"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/nu15153453","article-title":"WISER Survivor Trial: combined effect of exercise and weight loss interventions on adiponectin and leptin levels in breast cancer survivors with overweight or obesity","volume":"15","author":"Lin D","year":"2023","unstructured":"Lin D, Sturgeon KM, Gordon BR, Brown JC, Sears DD, Sarwer DB, Schmitz KH. WISER Survivor Trial: combined effect of exercise and weight loss interventions on adiponectin and leptin levels in breast cancer survivors with overweight or obesity. Nutrients. 2023, 15:10.3390\/nu15153453","journal-title":"Nutrients"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010097","article-title":"The role of adipokines in tumor progression and its association with obesity","volume":"12","author":"Kim JW","year":"2024","unstructured":"Kim JW, Kim JH, Lee YJ. The role of adipokines in tumor progression and its association with obesity. Biomedicines. 2024, 12:10.3390\/biomedicines12010097","journal-title":"Biomedicines"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168970","article-title":"Combination of blood adiponectin and leptin levels is a predictor of biochemical recurrence in prostate cancer invading the surrounding adipose tissue","volume":"25","author":"Suzuki A","year":"2024","unstructured":"Suzuki A, Sato S, Nakaigawa N, Kishida T, Miyagi Y. Combination of blood adiponectin and leptin levels is a predictor of biochemical recurrence in prostate cancer invading the surrounding adipose tissue. Int J Mol Sci. 2024, 25:10.3390\/ijms25168970","journal-title":"Int J Mol Sci"},{"key":"ref51","article-title":"Obesity, adipokines, and prostate cancer (review)","volume":"28","author":"Baillargeon J","year":"2006","unstructured":"Baillargeon J, Rose DP. Obesity, adipokines, and prostate cancer (review). Int J Oncol. 2006, 28:737-45.","journal-title":"Int J Oncol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-25-0342","article-title":"Assessment of adipokine and inflammation biomarkers with cancer risk among Chinese men: a prospective cohort study","volume":"34","author":"DeMoulin D","year":"2025","unstructured":"DeMoulin D, Cai H, Cai Q, Zheng W, Shu XO. Assessment of adipokine and inflammation biomarkers with cancer risk among Chinese men: a prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2025, 34:2104-16. 10.1158\/1055-9965.EPI-25-0342","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4021623","article-title":"Visfatin induces inflammation and insulin resistance via the NF-\u03baB and STAT3 signaling pathways in hepatocytes","volume":"2019","author":"Heo YJ","year":"2019","unstructured":"Heo YJ, Choi SE, Jeon JY, et al.. Visfatin induces inflammation and insulin resistance via the NF-\u03baB and STAT3 signaling pathways in hepatocytes. J Diabetes Res. 2019, 2019:10.1155\/2019\/4021623","journal-title":"J Diabetes Res"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110869","article-title":"Effects of a high-fat diet on spontaneous metastasis of Lewis lung carcinoma in plasminogen activator inhibitor-1 deficient and wild-type mice","volume":"9","author":"Yan L","year":"2014","unstructured":"Yan L, DeMars LC. Effects of a high-fat diet on spontaneous metastasis of Lewis lung carcinoma in plasminogen activator inhibitor-1 deficient and wild-type mice. PLoS One. 2014, 9:10.1371\/journal.pone.0110869","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v2.i12.384","article-title":"IL-6\/IL-6R as a potential key signaling pathway in prostate cancer development","volume":"2","author":"Azevedo A","year":"2011","unstructured":"Azevedo A, Cunha V, Teixeira AL, Medeiros R. IL-6\/IL-6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol. 2011, 2:384-96. 10.5306\/wjco.v2.i12.384","journal-title":"World J Clin Oncol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4029","article-title":"TLR9 signaling through NF-\u03baB\/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells","volume":"6","author":"Moreira D","year":"2015","unstructured":"Moreira D, Zhang Q, Hossain DM, et al.. TLR9 signaling through NF-\u03baB\/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells. Oncotarget. 2015, 6:17302-13. 10.18632\/oncotarget.4029","journal-title":"Oncotarget"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.4283","article-title":"Obesity and cancer mechanisms: tumor microenvironment and inflammation","volume":"34","author":"Iyengar NM","year":"2016","unstructured":"Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and cancer mechanisms: tumor microenvironment and inflammation. J Clin Oncol. 2016, 34:4270-6. 10.1200\/JCO.2016.67.4283","journal-title":"J Clin Oncol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13586","article-title":"Tumor necrosis factor-\u03b1 induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation","volume":"109","author":"Maolake A","year":"2018","unstructured":"Maolake A, Izumi K, Natsagdorj A, et al.. Tumor necrosis factor-\u03b1 induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation. Cancer Sci. 2018, 109:1524-31. 10.1111\/cas.13586","journal-title":"Cancer Sci"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70231","article-title":"Myeloid-derived suppressor cells in cancer: mechanistic insights and targeted therapeutic innovations","volume":"6","author":"Hu T","year":"2025","unstructured":"Hu T, Zhai J, Yang Z, et al.. Myeloid-derived suppressor cells in cancer: mechanistic insights and targeted therapeutic innovations. MedComm (2020). 2025, 6:10.1002\/mco2.70231","journal-title":"MedComm (2020)"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3390\/biology9120434","article-title":"Prostaglandin E2 and cancer: insight into tumor progression and immunity","volume":"9","author":"Finetti F","year":"2020","unstructured":"Finetti F, Travelli C, Ercoli J, Colombo G, Buoso E, Trabalzini L. Prostaglandin E2 and cancer: insight into tumor progression and immunity. Biology (Basel). 2020, 9:10.3390\/biology9120434","journal-title":"Biology (Basel)"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1381803","article-title":"Exploration of the causal relationship between inflammatory cytokines and prostate carcinoma: a comprehensive Mendelian randomization study","volume":"14","author":"Cai X","year":"2024","unstructured":"Cai X, Wang D, Ding C, Li Y, Zheng J, Xue W. Exploration of the causal relationship between inflammatory cytokines and prostate carcinoma: a comprehensive Mendelian randomization study. Front Oncol. 2024, 14:10.3389\/fonc.2024.1381803","journal-title":"Front Oncol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2005.10.002","article-title":"The risks and benefits of cyclo-oxygenase-2 inhibitors in prostate cancer: a review","volume":"3","author":"Sooriakumaran P","year":"2005","unstructured":"Sooriakumaran P, Kaba R. The risks and benefits of cyclo-oxygenase-2 inhibitors in prostate cancer: a review. Int J Surg. 2005, 3:278-85. 10.1016\/j.ijsu.2005.10.002","journal-title":"Int J Surg"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1099811","article-title":"Cyclooxygenase-2-prostaglandin E2 pathway: a key player in tumor-associated immune cells","volume":"13","author":"Jin K","year":"2023","unstructured":"Jin K, Qian C, Lin J, Liu B. Cyclooxygenase-2-prostaglandin E2 pathway: a key player in tumor-associated immune cells. Front Oncol. 2023, 13:10.3389\/fonc.2023.1099811","journal-title":"Front Oncol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases","volume":"23","author":"Buonacera A","year":"2022","unstructured":"Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022, 23:10.3390\/ijms23073636","journal-title":"Int J Mol Sci"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092760","article-title":"The relationship between hematological markers of systemic inflammation (neutrophil-to-lymphocyte, platelet-to-lymphocyte, lymphocyte-to-monocyte ratios) and ultrasound disease activity parameters in patients with rheumatoid arthritis","volume":"9","author":"Targo\u0144ska-St\u0119pniak B","year":"2020","unstructured":"Targo\u0144ska-St\u0119pniak B, Zwolak R, Piotrowski M, Grzechnik K, Majdan M. The relationship between hematological markers of systemic inflammation (neutrophil-to-lymphocyte, platelet-to-lymphocyte, lymphocyte-to-monocyte ratios) and ultrasound disease activity parameters in patients with rheumatoid arthritis. J Clin Med. 2020, 9:10.3390\/jcm9092760","journal-title":"J Clin Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000043048","article-title":"The supplementary value of the neutrophil-to-lymphocyte ratio in the diagnosis of rheumatoid arthritis","volume":"104","author":"Yang X","year":"2025","unstructured":"Yang X. The supplementary value of the neutrophil-to-lymphocyte ratio in the diagnosis of rheumatoid arthritis. Medicine (Baltimore). 2025, 104:10.1097\/MD.0000000000043048","journal-title":"Medicine (Baltimore)"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002544","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in prostate cancer: a systematic review and meta-analysis","volume":"95","author":"Yin X","year":"2016","unstructured":"Yin X, Xiao Y, Li F, Qi S, Yin Z, Gao J. Prognostic role of neutrophil-to-lymphocyte ratio in prostate cancer: a systematic review and meta-analysis. Medicine (Baltimore). 2016, 95:10.1097\/MD.0000000000002544","journal-title":"Medicine (Baltimore)"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1392","article-title":"Pretreatment neutrophil-to-lymphocyte ratio as a potential prognostic biomarker for newly diagnosed patients with metastatic castration-sensitive prostate cancer","volume":"4","author":"Salah S","year":"2021","unstructured":"Salah S, Abu-Hijlih R, Abuhijla F, Tamimi F, Al-Tell A, Shahait M. Pretreatment neutrophil-to-lymphocyte ratio as a potential prognostic biomarker for newly diagnosed patients with metastatic castration-sensitive prostate cancer. Cancer Rep (Hoboken). 2021, 4:10.1002\/cnr2.1392","journal-title":"Cancer Rep (Hoboken)"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.164198","article-title":"Association of the neutrophil-to-lymphocyte ratio and prostate cancer detection rates in patients via contemporary multi-core prostate biopsy","volume":"18","author":"Oh JJ","year":"2016","unstructured":"Oh JJ, Kwon O, Lee JK, Byun SS, Lee SE, Lee S, Hong SK. Association of the neutrophil-to-lymphocyte ratio and prostate cancer detection rates in patients via contemporary multi-core prostate biopsy. Asian J Androl. 2016, 18:937-41. 10.4103\/1008-682X.164198","journal-title":"Asian J Androl"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001473","article-title":"Pretreatment neutrophil-to-lymphocyte ratio: a predictor of advanced prostate cancer and biochemical recurrence in patients receiving radical prostatectomy","volume":"94","author":"Zhang GM","year":"2015","unstructured":"Zhang GM, Zhu Y, Ma XC, et al.. Pretreatment neutrophil-to-lymphocyte ratio: a predictor of advanced prostate cancer and biochemical recurrence in patients receiving radical prostatectomy. Medicine (Baltimore). 2015, 94:10.1097\/MD.0000000000001473","journal-title":"Medicine (Baltimore)"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1177\/15579883241234747","article-title":"Prognostic value of lymphocyte-to-monocyte ratio (LMR) in patients with prostate cancer: a systematic review and meta-analysis","volume":"18","author":"Xiang Q","year":"2024","unstructured":"Xiang Q, Liu Y, Xiao J, Ou L, Du J. Prognostic value of lymphocyte-to-monocyte ratio (LMR) in patients with prostate cancer: a systematic review and meta-analysis. Am J Mens Health. 2024, 18:10.1177\/15579883241234747","journal-title":"Am J Mens Health"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2025.07.001","article-title":"Cancer and cardiovascular disease: shared risk factors, mechanisms, and clinical implications: JACC: CardioOncology State-of-the-Art Review","volume":"7","author":"Alhuneafat L","year":"2025","unstructured":"Alhuneafat L, Guha A, Blaes A, Konety SH. Cancer and cardiovascular disease: shared risk factors, mechanisms, and clinical implications: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2025, 7:453-69. 10.1016\/j.jaccao.2025.07.001","journal-title":"JACC CardioOncol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097910","article-title":"Atherosclerosis and Inflammation: insights from the Theory of General Pathological Processes","volume":"24","author":"Gusev E","year":"2023","unstructured":"Gusev E, Sarapultsev A. Atherosclerosis and Inflammation: insights from the Theory of General Pathological Processes. Int J Mol Sci. 2023, 24:10.3390\/ijms24097910","journal-title":"Int J Mol Sci"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2223-4683.2015.04.12","article-title":"Inflammation in prostate cancer progression and therapeutic targeting","volume":"4","author":"Stark T","year":"2015","unstructured":"Stark T, Livas L, Kyprianou N. Inflammation in prostate cancer progression and therapeutic targeting. Transl Androl Urol. 2015, 4:455-63. 10.3978\/j.issn.2223-4683.2015.04.12","journal-title":"Transl Androl Urol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000003412","article-title":"Inflammation in cardio-oncology and psychological disorders: mechanisms, biomarkers, pain management, and therapeutic strategies","volume":"87","author":"Beniwal SS","year":"2025","unstructured":"Beniwal SS, Calder\u00f3n DC, Baweja T, et al.. Inflammation in cardio-oncology and psychological disorders: mechanisms, biomarkers, pain management, and therapeutic strategies. Ann Med Surg (Lond). 2025, 87:4229-36. 10.1097\/MS9.0000000000003412","journal-title":"Ann Med Surg (Lond)"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.5493\/wjem.v5.i1.21","article-title":"Consolidated and emerging inflammatory markers in coronary artery disease","volume":"5","author":"Lubrano V","year":"2015","unstructured":"Lubrano V, Balzan S. Consolidated and emerging inflammatory markers in coronary artery disease. World J Exp Med. 2015, 5:21-32. 10.5493\/wjem.v5.i1.21","journal-title":"World J Exp Med"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.301174","article-title":"Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community","volume":"33","author":"Schnabel RB","year":"2013","unstructured":"Schnabel RB, Yin X, Larson MG, et al.. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol. 2013, 33:1728-33. 10.1161\/ATVBAHA.112.301174","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-023-03638-5","article-title":"Association of systemic immune inflammatory index with all-cause and cause-specific mortality among individuals with type 2 diabetes","volume":"23","author":"Chen C","year":"2023","unstructured":"Chen C, Chen Y, Gao Q, Wei Q. Association of systemic immune inflammatory index with all-cause and cause-specific mortality among individuals with type 2 diabetes. BMC Cardiovasc Disord. 2023, 23:10.1186\/s12872-023-03638-5","journal-title":"BMC Cardiovasc Disord"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01424-2","article-title":"Cardiovascular impact of androgen deprivation therapy: from basic biology to clinical practice","volume":"25","author":"Kim J","year":"2023","unstructured":"Kim J, Freeman K, Ayala A, Mullen M, Sun Z, Rhee JW. Cardiovascular impact of androgen deprivation therapy: from basic biology to clinical practice. Curr Oncol Rep. 2023, 25:965-77. 10.1007\/s11912-023-01424-2","journal-title":"Curr Oncol Rep"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1177\/1756287215617872","article-title":"Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?","volume":"8","author":"Zareba P","year":"2016","unstructured":"Zareba P, Duivenvoorden W, Leong DP, Pinthus JH. Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?. Ther Adv Urol. 2016, 8:118-29. 10.1177\/1756287215617872","journal-title":"Ther Adv Urol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-019-0247-5","article-title":"Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease","volume":"17","author":"Jaiswal S","year":"2020","unstructured":"Jaiswal S, Libby P. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nat Rev Cardiol. 2020, 17:137-44. 10.1038\/s41569-019-0247-5","journal-title":"Nat Rev Cardiol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-025-00654-8","article-title":"Clonal hematopoiesis of indeterminate potential: a multisystem hub bridging hematopoietic dysfunction with non-hematopoietic diseases","volume":"12","author":"Zhang JL","year":"2025","unstructured":"Zhang JL, Tong SL, Zhuang QQ, Jin SJ, Li JQ, Sun J. Clonal hematopoiesis of indeterminate potential: a multisystem hub bridging hematopoietic dysfunction with non-hematopoietic diseases. Mil Med Res. 2025, 12:10.1186\/s40779-025-00654-8","journal-title":"Mil Med Res"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang Y","year":"2021","unstructured":"Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021, 18:2114-27. 10.1038\/s41423-021-00740-6","journal-title":"Cell Mol Immunol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-023-09838-w","article-title":"Exploring the role of the inflammasomes on prostate cancer: interplay with obesity","volume":"24","author":"P\u00e9rez-G\u00f3mez JM","year":"2023","unstructured":"P\u00e9rez-G\u00f3mez JM, Montero-Hidalgo AJ, Fuentes-Fayos AC, et al.. Exploring the role of the inflammasomes on prostate cancer: interplay with obesity. Rev Endocr Metab Disord. 2023, 24:1165-87. 10.1007\/s11154-023-09838-w","journal-title":"Rev Endocr Metab Disord"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.732192","article-title":"Toll like receptors as sensors of the tumor microbial dysbiosis: implications in cancer progression","volume":"9","author":"Le Noci V","year":"2021","unstructured":"Le Noci V, Bernardo G, Bianchi F, Tagliabue E, Sommariva M, Sfondrini L. Toll like receptors as sensors of the tumor microbial dysbiosis: implications in cancer progression. Front Cell Dev Biol. 2021, 9:10.3389\/fcell.2021.732192","journal-title":"Front Cell Dev Biol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan T","year":"2022","unstructured":"Duan T, Du Y, Xing C, Wang HY, Wang RF. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022, 13:10.3389\/fimmu.2022.812774","journal-title":"Front Immunol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2180373","article-title":"Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome","volume":"2018","author":"Mihai S","year":"2018","unstructured":"Mihai S, Codrici E, Popescu ID, et al.. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res. 2018, 2018:10.1155\/2018\/2180373","journal-title":"J Immunol Res"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010263","article-title":"Inflammation and oxidative stress in chronic kidney disease - potential therapeutic role of minerals, vitamins and plant-derived metabolites","volume":"21","author":"Rapa SF","year":"2019","unstructured":"Rapa SF, Di Iorio BR, Campiglia P, Heidland A, Marzocco S. Inflammation and oxidative stress in chronic kidney disease - potential therapeutic role of minerals, vitamins and plant-derived metabolites. Int J Mol Sci. 2019, 21:10.3390\/ijms21010263","journal-title":"Int J Mol Sci"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-024-05409-z","article-title":"Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammation","volume":"43","author":"Paal K","year":"2024","unstructured":"Paal K, Stranz B, Thurner EM, Niedrist T, Renner W, Langsenlehner T. Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammation. World J Urol. 2024, 43:10.1007\/s00345-024-05409-z","journal-title":"World J Urol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3390\/nu15234858","article-title":"Decoding the influence of obesity on prostate cancer and its transgenerational impact","volume":"15","author":"Santos-Pereira M","year":"2023","unstructured":"Santos-Pereira M, Pereira SC, Rebelo I, Spadella MA, Oliveira PF, Alves MG. Decoding the influence of obesity on prostate cancer and its transgenerational impact. Nutrients. 2023, 15:10.3390\/nu15234858","journal-title":"Nutrients"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100130","article-title":"Regulatory T cell function in autoimmune disease","volume":"4","author":"Rajendeeran A","year":"2021","unstructured":"Rajendeeran A, Tenbrock K. Regulatory T cell function in autoimmune disease. J Transl Autoimmun. 2021, 4:10.1016\/j.jtauto.2021.100130","journal-title":"J Transl Autoimmun"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2017.06.001","article-title":"Cardiovascular disease and cancer: evidence for shared disease pathways and pharmacologic prevention","volume":"263","author":"Masoudkabir F","year":"2017","unstructured":"Masoudkabir F, Sarrafzadegan N, Gotay C, et al.. Cardiovascular disease and cancer: evidence for shared disease pathways and pharmacologic prevention. Atherosclerosis. 2017, 263:343-51. 10.1016\/j.atherosclerosis.2017.06.001","journal-title":"Atherosclerosis"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao H","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021, 6:10.1038\/s41392-021-00658-5","journal-title":"Signal Transduct Target Ther"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102984","article-title":"Inflammation as a driver of prostate cancer metastasis and therapeutic resistance","volume":"12","author":"Archer M","year":"2020","unstructured":"Archer M, Dogra N, Kyprianou N. Inflammation as a driver of prostate cancer metastasis and therapeutic resistance. Cancers (Basel). 2020, 12:10.3390\/cancers12102984","journal-title":"Cancers (Basel)"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5980387","article-title":"IL-6 signaling link between inflammatory tumor microenvironment and prostatic tumorigenesis","volume":"2022","author":"Ene CV","year":"2022","unstructured":"Ene CV, Nicolae I, Geavlete B, Geavlete P, Ene CD. IL-6 signaling link between inflammatory tumor microenvironment and prostatic tumorigenesis. Anal Cell Pathol (Amst). 2022, 2022:10.1155\/2022\/5980387","journal-title":"Anal Cell Pathol (Amst)"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/9936087","article-title":"A novel nomogram combined the aggregate index of systemic inflammation and PIRADS score to predict the risk of clinically significant prostate cancer","volume":"2023","author":"Xie W","year":"2023","unstructured":"Xie W, Xu Z, Qiu Y, Ye W, Zhang Z, Wang C, Zang J. A novel nomogram combined the aggregate index of systemic inflammation and PIRADS score to predict the risk of clinically significant prostate cancer. Biomed Res Int. 2023, 2023:10.1155\/2023\/9936087","journal-title":"Biomed Res Int"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000003451","article-title":"Prostate cancer risk reduction: promising prevention practices and insights","volume":"87","author":"Obeagu EI","year":"2025","unstructured":"Obeagu EI. Prostate cancer risk reduction: promising prevention practices and insights. Ann Med Surg (Lond). 2025, 87:4344-55. 10.1097\/MS9.0000000000003451","journal-title":"Ann Med Surg (Lond)"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.15167\/2421-4248\/jpmh2022.63.2S3.2749","article-title":"Effects of the Mediterranean diet polyphenols on cancer development","volume":"63","author":"Dayi T","year":"2022","unstructured":"Dayi T, Oniz A. Effects of the Mediterranean diet polyphenols on cancer development. J Prev Med Hyg. 2022, 63:74-80. 10.15167\/2421-4248\/jpmh2022.63.2S3.2749","journal-title":"J Prev Med Hyg"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1629896","article-title":"Genetic factors may load the gun, but environmental factors pull the trigger: MedDiet and DII in rheumatoid arthritis","volume":"12","author":"A\u00e7\u0131kal\u0131n G\u00f6kt\u00fcrk B","year":"2025","unstructured":"A\u00e7\u0131kal\u0131n G\u00f6kt\u00fcrk B, Sanlier N. Genetic factors may load the gun, but environmental factors pull the trigger: MedDiet and DII in rheumatoid arthritis. Front Nutr. 2025, 12:10.3389\/fnut.2025.1629896","journal-title":"Front Nutr"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1595000","article-title":"Inflammatory-based prognostic indicators in prostate cancer: evaluating NLR, PLR, and SII in relation to Cambridge and ISUP classifications","volume":"15","author":"Patrza\u0142ek P","year":"2025","unstructured":"Patrza\u0142ek P, Fro\u0144 A, Mielczarek M, et al.. Inflammatory-based prognostic indicators in prostate cancer: evaluating NLR, PLR, and SII in relation to Cambridge and ISUP classifications. Front Oncol. 2025, 15:10.3389\/fonc.2025.1595000","journal-title":"Front Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437533-inflammation-beyond-the-prostate-the-role-of-systemic-inflammatory-disorders-in-prostate-carcinogenesis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T17:37:10Z","timestamp":1766165830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437533-inflammation-beyond-the-prostate-the-role-of-systemic-inflammatory-disorders-in-prostate-carcinogenesis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":100,"URL":"https:\/\/doi.org\/10.7759\/cureus.99640","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,19]]}}}